Moderna charges significantly more for its experimental coronavirus vaccine than competing treatments


Moderna, the first pharmaceutical company to conduct human trials of a coronavirus vaccine in the United States, costs up to $ 37 per dose for its experimental treatment. That’s more than three times what some industry competitors say they plan to charge for their vaccines.Individuals are expected to need up to two doses to fully immunize them against COVID-19, which means treatment could cost up to $ 74 per person.

As of yet, there is no approved vaccine to protect people from the novel coronavirus. But Moderna appears to have a leg up on the many drugmakers and biotech companies working to develop one. Cambridge, Massachusetts-based company started a phase III trial of his vaccine at the end of July, following the promising results of a first test at the beginning of the summer.


Please enter your comment!
Please enter your name here